High-risk bladder cancer: improving outcomes with perioperative chemotherapy

Despite treatment with radical cystectomy and pelvic lymph node dissection, muscle invasive bladder cancer has a relapse rate of 50%. Patients can develop regionally advanced or metastatic disease that ultimately leads to death. The addition of neoadjuvant or adjuvant chemotherapy to reduce the risk...

Full description

Bibliographic Details
Main Authors: Daniel Y.C. Heng, Jorge A. Garcia
Format: Article
Language:English
Published: Frontiers Media S.A. 2011-12-01
Series:Oncology Reviews
Subjects:
Online Access:http://oncologyreviews.org/index.php/or/article/view/103